[An analysis of clinical and genetic feature in pulmonary artery sarcoma].

Zhonghua Jie He He Hu Xi Za Zhi

State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Department of Pulmonary and Critial Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.

Published: March 2025

To retrospectively analyze the clinical, imaging, pathological and genetic features in patients with pulmonary artery sarcoma (PAS) in a single center, and to investigate the disease origin of PAS, as well as its relationship with other pulmonary vascular diseases. We retrospectively identified and analyzed clinical features of 13 cases with PAS those were admitted in the First Affiliated Hospital of Guangzhou Medical University between January 2015 and January 2021. Whole exome sequencing (WES) was performed to further analyze their genetic characteristics in 8 postoperative specimens. The average age of PAS patients was 26-67 (43.2±11.6) years, and the median time from symptom to diagnosis was 8 months (IQR: 3, 11.5). The most common symptom of PAS was shortness of breath (84.6%), and the most common complication was pulmonary hypertension (69.2%).A total of 5 genes with specific mutations in PAS patients were identified by genomic analysis. Compared with genetic features of pulmonary embolism (PE), pulmonary arterial hypertension (PAH) and lung cancer (LC),we found genetic similarity between PAS and LC. Using KEEG database, we identified that most of the PAS-mutated genes belonged to cancer-enriched signaling pathways. PAS is a kind of malignant tumor located in the pulmonary vascular trunk, without a good prognosis and specific clinical manifstations. The occurrence of PAS may be associathed with mutations of MDM2, PIK3CA and TP53.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn112147-20240731-00450DOI Listing

Publication Analysis

Top Keywords

pas
9
pulmonary artery
8
genetic features
8
pulmonary vascular
8
pas patients
8
pulmonary
7
genetic
5
[an analysis
4
clinical
4
analysis clinical
4

Similar Publications

Management of the placenta accreta spectrum (PAS) in resource-limited settings poses significant challenges. Traditional approaches, which often involve hysterectomy and extensive technology in all the patients are being replaced by individualized treatment plans considering each patient's specific clinical situation, available resources, and team expertise. Using ultrasonographic and surgical staging based on PAS topographic classification can help design tailored surgical plans and optimize resource use.

View Article and Find Full Text PDF

The use of self-healing mineralized hydrogels in 3D printing has demonstrated significant advantages, including enhanced printing accuracy and the ability to maintain high shape fidelity throughout the printing process. After conducting an initial optimization study, we incorporated our self-healing mineralized hydrogel into semi-solid extrusion-based 3D printing to print diclofenac-loaded oral films. The dependence of the print speed on the nature of the material was established by varying the print speed.

View Article and Find Full Text PDF

The lipid profiles in raw fat (RF) and thermal-extracted fat (TF) from yak under hydroxyl radical-induced oxidative stress were investigated. Both hydroxyl radical and thermal extraction accelerated lipid oxidation. A total of 1168 lipids were identified and classified into 18 lipid categories.

View Article and Find Full Text PDF

Chlorogenic acid attenuates pyrrolizidine alkaloid-induced liver injury through modulation of the SIRT1/FXR signaling pathway.

Chin Med

March 2025

Shanghai Key Laboratory of Complex Prescriptions, The MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Background: Pyrrolizidine alkaloids (PAs), recognized globally for their hepatotoxic properties, significantly contribute to liver damage through an imbalance in bile acid homeostasis. Addressing this imbalance is crucial for therapeutic interventions in PA-related liver injuries. Chlorogenic acid (Cga), a phenolic compound derived from medicinal plants, has demonstrated hepato-protective effects across a spectrum of liver disorders.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!